Références - Mon combat pour la vie: Le cancer chez les enfants et les adolescents au Canada

RÉFÉRENCES

1. Albright AL. Pediatric brain tumors. CA Cancer J Clin 1993;43:272-88.

2. Altman AJ. Chronic leukemias of childhood. Dans : Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. Philadelphie: Lippincott, 1989:383-96.

3. American Cancer Society. Unproven methods of cancer management. Gerson method. CA Cancer J Clin 1990;40:252-6.

4. American Cancer Society. Unproven methods of cancer management. Greek cancer cure. CA Cancer J Clin 1990;40:368-71.

5. American Cancer Society. Unproven methods of cancer management. Laetrile. CA Cancer J Clin 1991;41:187-92.

6. American Cancer Society. Questionable methods of cancer management. Questionable cancer practices in Tijuana and other Mexican border clinics. CA Cancer J Clin 1991;41:310-9.

7. American Cancer Society. Questionable methods of cancer management. Immuno-augmentative therapy (IAT). CA Cancer J Clin 1991;41:357-64.

8. American Cancer Society. Questionable methods of cancer management: 'Nutritional' therapies. CA Cancer J Clin 1993;43:309-19.

9. American Joint Committee on Cancer. Beahrs OH, Henson DE, Hutter RVP, Myers MH, eds. Manual for staging of cancer. Troisième édition. Philadelphie : J.B. Lippincott Company, 1988.

10. Andrykowski MA. Psychosocial factors in bone marrow transplantation: a review and recommendations for research. Bone Marrow Transplant 1994;13:357-75.

11. Anholt UV, Fritz GK, Keener M. Self-concept in survivors of childhood and adolescent cancer. J Psychosoc Oncol 1993;11:1-16.

12. Armitage JO. Treatment of non-Hodgkin's lymphoma. N Engl J Med 1993;328:1023-30.

13. Band PR, Gaudette LA, Hill GB, Holowaty EJ, Huchcroft SA, Johnston GM, Makomaski Illing EM, Mao Y, Semenciw RM. Développement du Registre canadien du cancer : incidence du cancer au Canada et dans les régions canadiennes, 1969 à 1988. Ottawa : Approvisionnements et Services Canada, 1993.

14. Baron MC. Advances in the care of children with brain tumors. J Neurosci Nurs 1991;23:39-43.

15. Barrett AJ, Horowitz MM, Pollock BH, Zhang M-J, Bortin MM, Buchanan GR, Camitta BM, Ochs J, Graham-Pole J, Rowlings PA, Rimm AA, Klein JP, Shuster JJ, Sobocinski KA, Gale RP. Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission. N Engl J Med 1994;331:1253-8.

16. Billet AL, Kornmehl E, Tarbell NJ, Weinstein HJ, Gelber RD, Ritz J, Sallan SE. Autologous bone marrow transplantation after a long first remission for children with recurrent acute lymphoblastic leukemia. Blood 1993;81:1651-7.

17. Birch JM, Marsden HB, Morris Jones PH, Pearson D, Blair V. Improvements in survival from childhood cancer: results of a population based survey over 30 years. BMJ 1988;296:1372-6.

18. Boice JD, Land CE. Ionizing radiation. Dans : Schottenfeld D, Fraumeni JF, eds. Cancer epidemiology and prevention. Philadelphie : W.B. Saunders Company, 1982:231-53.

19. Bonadonna G, Santoro A, Viviani S, Valagussa P. Treatment strategies for Hodgkin's disease. Semin Hematol 1988;25:51-7.

20. Brada M, James ND, Pinkerton CR. Treatment of brain tumours in children less than 3 years of age. Eur J Cancer 1993;29A:2075-6.

21. Breslow NE, Olshan A, Beckwith JB, Green DM. Epidemiology of Wilms' Tumor. Med Pediatr Oncol 1993;21:172-81.

22. Breslow NE, Beckwith JB. Epidemiological features of Wilms' tumor: results of the National Wilms' Tumor Study. J Natl Cancer Inst 1982;68:429-36.

23. Breyer J, Kunin H, Kalish LA, Patenaude AF. The adjustment of siblings of pediatric cancer patients - a sibling and parent perspective. Psycho-oncol 1993;2:201-8.

24. Chang PN. Psychosocial needs of long-term childhood cancer survivors: a review of literature. Pediatrician 1991;18:20-4.

25. Cincotta N. Psychosocial issues in the world of children with cancer. Cancer 1993;71(Suppl):3251-60.

26. Clarke-Steffen L. A model of the family transition to living with childhood cancer. Ca Prac 1993;1:285-92.

27. Clavell LA, Gelber RD, Cohen HJ, Hitchcock-Bryan S, Cassady JR, Tarbell NJ, Blattner SR, Tantravahi R, Leavitt P, Sallan SE. Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia. N Engl J Med 1986;315:657-63.

28. Coppes MJ, de Kraker J, van Dijken PJ, Perry HJM, Delemarre JFM, Tournade MF, Lemerle J, Voüte PA. Bilateral Wilms' tumor: long-term survival and some epidemiological features. J Clin Oncol 1989;7:310-5.

29. Crist WM, Kun LE. Common solid tumors of childhood. N Engl J Med 1991;324:461-71.

30. Deasy-Spinetta P. School issues and the child with cancer. Cancer 1993;71(Suppl):3261-4.

31. DeLaat CA, Lampkin BC. Long-term survivors of childhood cancer: evaluation and identification of sequelae of treatment. CA Cancer J Clin 1992;42:263-82.

32. DeSpain JD. Dermatologic toxicity of chemotherapy. Semin Oncol 1992;19:501-7.

33. Doll R. Are we winning the fight against cancer? An epidemiological assessment. EACR-Mühlbock memorial lecture. Eur J Cancer 1990;26:500-8.

34. Draper GJ. Genetic aspects of the aetiology of childhood cancer. Dans : Muller HJ, Weber W, eds. Familial Cancer. New York: Karger, 1985:139-141.

35. Ettinger RS, Heiney SP. Cancer in adolescents and young adults. Cancer 1993;71(Suppl):3276-80.

36. Foley GV, Hannigan Whittam E. Care of the child dying of cancer: part I. CA Cancer J Clin 1990;40:327-54.

37. Foley GV, Hannigan Whittam E. Care of the child dying of cancer: part II. CA Cancer J Clin 1991;41:52-60.

38. Garrison FH. A system of pediatrics. Volume 1. Philadelphie : W.B. Saunders, 1923:1-61.

39. Glauser TA, Packer RJ. Cognitive deficits in long-term survivors of childhood brain tumors. Childs Nerv Syst 1991;7:2-12.

40. Gordon BL, ed. Current medical information and terminology. Quatrième édition. Chicago : American Medical Association, 1971.

41. Graham M. Non-Hodgkin's lymphomas. Pediatr Annals 1988;17:192-203.

42. Greaves MF. Speculations on the cause of childhood acute lymphoblastic leukemia. Leukemia 1988;2:120-5.

43. Green DM. Effects of treatment for childhood cancer on vital organ systems. Cancer 1993;71(Suppl):3299-305.

44. Green DM, Zevon MA, Hall B. Achievement of life goals by adult survivors of modern treatment for childhood cancer. Cancer 1991;67:206-13.

45. Greenberg HS, Kazak AE, Meadows AT. Psychologic functioning in 8- to 16-year-old cancer survivors and their parents. J Pediatr 1989;114:488-93.

46. Haase JE, Rostad M. Experiences of completing cancer therapy: children's perspectives. Oncol Nurs Forum 1994;21:1483-94.

47. Hays DM. Adult survivors of childhood cancer. Cancer 1993;71(Suppl):3306-9.

48. Hays DM, Landsverk J, Sallan SE, Hewett KD, Farkas Patenaude A, Schoonover D, Zilber SL, Ruccione K, Siegel SE. Educational, occupational, and insurance status of childhood cancer survivors in their fourth and fifth decades of life. J Clin Oncol 1992;10:1397-1406.

49. Heiney SP. Adolescents with cancer. Sexual and reproductive issues. Cancer Nurs 1989;12:95-101.

50. Hempelmann LH, Hall WJ, Phillips M, Cooper RA, Ames WR. Neoplasms in persons treated with x-rays in infancy: fourth survey in 20 years. J Natl Cancer Inst 1975;55:519-30.

51. Hockenberry-Eaton M, Minick P. Living with cancer: children with extraordinary courage. Oncol Nurs Forum 1994;21:1025-31.

52. Horowitz ME, Tsokos MG, DeLaney TF. Ewing's sarcoma. CA Cancer J Clin 1992;42:300-20.

53. Horowitz MM, Bortin MM. Results of bone marrow transplants from human leukocyte antigen-identical sibling donors for treatment of childhood leukemias. Am J Pediatr Hematol Oncol 1993;15:56-64.

54. Hvizdala EV, Berard C, Callihan T, Falletta J, Sabio H, Shuster JJ, Sullivan M, Wharam MD. Nonlymphoblastic lymphoma in children - histology and stage-related response to therapy: a Pediatric Oncology Group study. J Clin Oncol 1991;9:1189-95.

55. Comité international des rédacteurs de revues médicales. Uniform requirements for manuscripts submitted to biomedical journals. N Engl J Med 1991;324:424-8.

56. Union internationale contre le cancer. Hermanek P, Sobin LH, eds. TNM Classification des tumeurs malignes. Quatrième édition. Paris : Springer, 1988.

57. Jarvis W. Helping your patients deal with questionable cancer treatments. CA Cancer J Clin 1986;36:293-301.

58. Jay SM, Elliott CH, Katz E, et Siegel SE. Cognitive-behavioral and pharmacologic interventions for children's distress during painful medical procedures. J Consult Clin Psychol 1987;55:860-5.

59. Jensen RD, Miller RW. Retinoblastoma: epidemiologic characteristics. N Engl J Med 1971;285:307-11.

60. Kinlen L. Evidence for an infective cause of childhood leukemia - comparison of a Scottish New Town with nuclear reprocessing sites in Britain. Lancet 1988;11:1323-7.

61. Konsler GK, Jones GR. Transition issues for survivors of childhood cancer and their health care providers. Ca Prac 1993;1:319-24.

62. Koocher GP, O'Malley JE. The Damocles syndrome: psychosocial consequences of surviving childhood cancer. New York: McGraw-Hill, c1981.

63. Kuttner L. Favorite stories: a hypnotic pain-reduction technique for children in acute pain. Am J Clin Hypn 1988;30:290-5.

64. Leventhal-Belfer L, Bakker AM, Russo CL. Parents of childhood cancer survivors: a descriptive look at their concerns and needs. J Psychosoc Oncol 1993;11:19-41.

65. Li FP, Fraumeni JF. Soft-tissue sarcomas, breast cancer, and other neoplasms: a familial syndrome. Ann Intern Med 1969;71:747-52.

66. Li FP. Cancer families: human models of susceptibility to neoplasia. Cancer Res 1988;48:5381-6.

67. Linet MS. The leukemias: epidemiologic aspects. Dans : Lilienfield A, ed. Monographs in epidemiology and biostatistics. Volume 6. New York: Oxford University Press, 1985.

68. Louie S, Schwartz RS. Immunodeficiency and the pathogenesis of lymphoma and leukemia. Semin Hematol 1987;15:171-8.

69. Lozowski SL. Views of childhood cancer survivors: selected perspectives. Cancer 1993;71(Suppl):3354-7.

70. MacMahon B. Prenatal x-ray exposure and childhood cancer. J Natl Cancer Inst 1962;28:1173-91.

71. MacMahon B. Is acute lymphoblastic leukemia in children virus-related? Am J Epidemiol 1992;136:916-24.

72. Maurer HM, Gehan EA, Beltangady M, Crist W, Dickman PS, Donalson SS, Fryer C, Hammond D, Hays DM, Herrmann J, Heyn R, Jones PM, Lawrence W, Newton W, Ortega J, Ragab AH, Raney RB, Ruymann FB, Soule E, Tefft M, Webber B, Wiener E, Wharam M, Vietti TJ. The Intergroup Rhabdomyosarcoma Study-II. Cancer 1993;71:1904-22.

73. McGrath PA. Pain assessment in children - a practical approach. Dans : Tyler DC, Krane EJ, eds. Advances in pain research and therapy. Vol 15. Pediatric Pain. New York: Raven Press, 1990:5-30.

74. McGrath PA. An assessment of children's pain: A review of behavioural physiological and direct scaling techniques. Pain 1987;31:147-76.

75. McGrath PJ, McAlpine L. Psychological perspectives on pediatric pain. J Pediatr 1993;122:S2-8.

76. McKeen EA, Bodurtha J, Meadows AT, Douglass EC, Mulvihill JJ. Rhabdomyosarcoma complicating multiple neurofibromatosis. J Pediatr 1978;93:992-3.

77. Meadows AT, Black B, Nesbit ME, Strong LC, Nicholson HS, Green DM, Hays DM, Lozowski SL. Long-term survival. Clinical care, research, and education. Cancer 1993;71(Suppl):3213-5.

78. Meadows AT, Baum E, Fossati-Bellani F, Green D, Jenkin RDT, Marsden B, Nesbit M, Newton W, Oberlin O, Sallan SG, Siegel S, Strong LC, Voute PA. Second malignant neoplasms in children: an update from the late effects study group. J Clin Oncol 1985;3:532-8.

79. Meister LA, Meadows AT. Late effects of childhood cancer therapy. Curr Probl Pediatr 1993;23:102-31 et 117-9.

80. Mettlin C. Dietary cancer prevention in children. Cancer 1993;71(Suppl):3367-9.

81. Meyers PA, Heller G, Healey JH, Huvos A, Applewhite A, Sun M, LaQuaglia M. Osteogenic sarcoma with clinically detectable metastasis at initial presentation. J Clin Oncol 1993;11:449-53.

82. Miller LL. Current status of G-CSF in support of chemotherapy and radiotherapy. Oncology 1993;7:67-88.

83. Miller RW. Relation between cancer and congenital defects in man. N Engl J Med 1966;275:87-93.

84. Miller RW. Neoplasia and Down's syndrome. Ann N Y Acad Sci 1970;171:637-44.

85. Mitchell EP. Gastrointestinal toxicity of chemotherapeutic agents. Semin Oncol 1992;19:566-79.

86. Montbriand MJ. An overview of alternate therapies chosen by patients with cancer. Oncol Nurs Forum 1994;21:1547-54.

87. Mosijczuk AD, Nigro MA, Thomas PRM, Burger PC, Krischer JP, Morantz RA, Kurdunowicz B, Mulne AF, Towbin RB, Freeman AI, Nigro ED, Friedman HS, Kun LE. Preradiation chemotherapy in advanced medulloblastoma. Cancer 1993;72:2755-62.

88. Mulhern RK, Wasserman AL, Friedman AG, Fairclough D. Social competence and behavioral adjustment of children who are long-term survivors of cancer. Pediatrics 1989;83:18-25.

89. Mulvihill JJ, Miller RW, Fraumeni JR. Genetics of Human Cancer; vol 3. New York: Raven Press, 1977.

90. Nathan DG, Oski FA, eds. Hematology of infancy and childhood. Quatrième édition. Vol 2. Toronto : W.B. Saunders Company, 1992:1101-449.

91. Institut national du cancer du Canada : Statistiques canadiennes sur le cancer 1995 Toronto, Canada, 1995.

92. National Research Council. Committee on the Biological Effects of Ionizing Radiation (BEIR). The effects on populations of exposure to low levels of ionizing radiation: 1980. Washington: National Academy Press, 1980.

93. National Research Council. Committee on the Biological Effects of Ionizing Radiations (BEIR). Health effects of exposure to low levels of ionizing radiation: BEIR V. Washington: National Academy Press, 1990.

94. Neglia JP, Nesbit ME. Care and treatment of long-term survivors of childhood cancer. Cancer 1993;71(Suppl):3386-91.

95. Nicholson HS, Byrne J. Fertility and pregnancy after treatment for cancer during childhood or adolescence. Cancer 1993;71(Suppl):3392-9.

96. Parkin DM, Stiller CA, Draper GJ, Bieber CA, Terracini B, Young JL, eds. International incidence of childhood cancer. Lyon : Centre international de recherche sur le cancer, 1988. CIRC Publication scientifique n^o 87.

97. Percy C, Van Holten V, Muir C, eds. International classification of diseases for oncology. Deuxième édition. Genève : Organisation mondiale de la santé, 1990.

98. Perry MC. Chemotherapeutic agents and hepatotoxicity. Semin Oncol 1992;19:551-65.

99. Peterson DE. Oral toxicity of chemotherapeutic agents. Semin Oncol 1992;19:478-91.

100. Pollack IF. Brain tumors in children. N Engl J Med 1994;331:1500-7.

101. Rando T, ed. Parental loss of a child. Champaign: Research Press Company, 1986.

102. Reaman GH, Bonfiglio J, Krailo M, Tebbie CK, Seikin S, Ettinger R, Zeltzer LK, Nachman JB, Rivera GK, Aboulafia A, Rosen DS. Cancer in adolescents and young adults. Cancer 1993;71(Suppl):3206-9.

103. Rivera GK, Pinkel D, Simone JV, Hancock ML, Crist WM. Treatment of acute lymphoblastic leukemia: 30 years' experience at St. Jude Children's Research Hospital. N Engl J Med 1993;329:1289-95.

104. Rivera GK, Pui C-H, Santana VM, Hancock ML, Mahmoud H, Sandlund JT, Ribeiro RC, Furman W, Marina N, Crist WM. Progress in the treatment of adolescents with acute lymphoblastic leukemia. Cancer 1993;71(Suppl):3400-5.

105. Robison LL. Issues in the consideration of intervention strategies in long-term survivors of childhood cancer. Cancer 1993;71(Suppl):3406-10.

106. Robison LL, Mertens A. Second tumors after treatment of childhood malignancies. Hematol Oncol Clin North Am 1993;7:401-15.

107. Robison LL, Stoker V, Frizzera G, Heinitz K, Meadows AT, Filipovich AH. Hodgkin's disease in pediatric patients with naturally occurring immunodeficiency. Am J Pediatr Hematol Oncol 1987;9:189-92.

108. Rosen DS. Transition to adult health care for adolescents and young adults with cancer. Cancer 1993;71(Suppl):3411-4.

109. Rosner F, Lee SL. Down's syndrome and acute leukemia: myeloblastic or lymphoblastic? Report of forty-three cases and review of the literature. Am J Med 1972;53:203-18.

110. Ruccione K, Weinberg K. Late effects in multiple body systems. Semin Oncol Nurs 1989;5:4-13.

111. Sagerman RH, Cassady JR, Tretter P, Ellsworth RM. Radiation induced neoplasia following external beam therapy for children with retinoblastoma. Am J Roentgenol Radium Ther Nucl Med 1969;105:529-35.

112. Savitz DA, Chen J. Parental occupation and childhood cancer: review of epidemiologic studies. Environ Health Prospect 1990;88:325-37.

113. Sawyer MG, Gannoni AF, Toogood IR, Antoniou G, Rice M. Children with cancer: The use of alternative therapies by children with cancer. Med J Aust 1994;160:320-2.

114. Shalet SM. Effects of cancer chemotherapy on gonadal function of patients. Cancer Treat Rev 1980;7:141-52.

115. Simone JV. Childhood leukemia as a model for cancer research: the Richard and Hinda Rosenthal Foundation Award lecture. Cancer Res 1979;39:4301-7.

116. Spinetta J, Deasy-Spinetta P. Living with childhood cancer. St. Louis: Mosby, 1981.

117. Statistique Canada. Causes de décès : 1985. La statistique de l'état civil Volume IV. Ottawa, 1986 : n^o 84-203 au catalogue.

118. Statistique Canada. Causes de décès : 1986. La statistique de l'état civil Volume IV. Ottawa, 1988 : n^o 84-203 au catalogue.

119. Statistique Canada. Causes de décès : 1987. Rapports sur la santé v.1, n^o 1, suppl. Ottawa, 1989 : n^o 82-003S au catalogue (inclus auparavant dans le n^o 82-208 au catalogue).

120. Statistique Canada. Causes de décès : 1988. Rapports sur la santé v.2, n^o 1, suppl.11. Ottawa, 1990 : n^o 82-003S au catalogue (inclus auparavant dans le n^o 84-203 au catalogue).

121. Statistique Canada. Causes de décès : 1989. Rapports sur la santé v.3, n^o 1, suppl.11. Ottawa, 1991 : n^o 82-003S11 au catalogue (inclus auparavant dans le n^o 84-203 au catalogue).

122. Statistique Canada. Causes de décès : 1990. Rapports sur la santé v.4, n^o 1, suppl.11. Ottawa, 1992 : n^o 82-003S11 (inclus auparavant dans le n^o 84-203 au catalogue).

123. Statistique Canada. Causes de décès : 1991. Ottawa, 1993 : n^o 84-208 au catalogue.

124. Statistique Canada. Causes de décès : 1992. Ottawa, 1994 : n^o 84-208 au catalogue.

125. Stewart A, Webb J, Giles D, Hewitt D. Malignant disease in childhood and diagnostic irradiation in utero. Lancet 1956;2 :447.

126. Sullivan MP, Fuller LM, Berard C, Ternberg J, Cantor AB, Leventhal BG. Comparative effectiveness of two combined modality regimens in the treatment of surgical stage III Hodgkin's disease in children : an 8-year follow-up study by the Pediatric Oncology Group. Am J Pediatr Hematol Oncol 1991;13 :450-8.

127. Tannock IF. Cell proliferation. Dans : Tannock IF, Hill RP, eds. The basic science of oncology. New York : McGraw-Hill, Inc. Health Professions Division, 1992 :154-77.

128. Secrétariat d'État du Canada. Guide du rédacteur de l'administration fédérale. Ottawa : Direction de l'information, Bureau des traductions, Secrétariat d'État, 1983.

129. Theriault G. Cancer risks due to exposure to electromagnetic fields. Recent Results Cancer Res 1990;120 :166-80.

130. Tomatis L, Aitio A, Day NE, Heseltine E, Kaldor J, Miller AB, Parkin DM, Riboli E, eds. Cancer: causes, occurrence and control. Lyon : Centre international de recherche sur le cancer, 1990:1-11. CIRC Publications scientifiques n^o 100.

131. Tournade MF, Com-Nougue C, Voute PA, Lemerle J, de Kraker J, Delemarre JFM, Burgers M, Habrand JL, Moorman CGM, Burger D, Rey A, Zucker JM, Carli M, Jereb B, Bey P, Gauthier F, Sandstedt B. Results of the Sixth International Society of Pediatric Oncology Wilms' tumor trial and study: a risk-adapted therapeutic approach in Wilms' tumor. J Clin Oncol 1993;11:1014-23.

132. Tubergen DG, Gilchrist GS, O'Brien RT, Coccia PF, Sather HN, Waskerwitz MJ, Hammond GD. Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Childrens Cancer Group phase III trial. J Clin Oncol 1993;11:527-37.

133. Washburn EP, Orza MJ, Berlin JA, Nicholson WJ, Todd AC, Frumkin H, Chalmers TC. Residential proximity to electricity transmission and distribution equipment and risk of childhood leukemia, childhood lymphoma, and childhood nervous system tumors: systematic review, evaluation, and meta-analysis. Cancer Causes Control 1994;5:299-309.

134. Weekes DP, Savedra MC. Adolescent cancer: coping with treatment-related pain. J Pediatr Nurs 1988;3:318-28.

135. Weinberg RA. Oncogenes and tumor suppressor genes. CA Cancer J Clin 1994;44:160-170.

136. Weiner MA, Leventhal BG, Marcus R, Brecher M, Ternberg J, Behm FG, Cantor A, Wharam M, Chauvenet A. Intensive chemotherapy and low-dose radiotherapy for the treatment of advanced-stage Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study. J Clin Oncol 1991;9:1591-8.

137. Wertheimer N, Leeper E. Electrical wiring configurations and childhood cancer. Am J Epidemiol 1979;109:273-84.

138. White L, Siegel SE, Quah TC. Non-Hodgkin's lymphomas in children. I. Patterns of disease and classification. Crit Rev Oncol Hematol 1992;13:55-71.

139. Woods WG, Tuchman M, Bernstein ML, Leclerc JM, Brisson L, Look T, Brodeur GM, Shimada H, Hann HL, Robinson LL, Shuster JJ, Lemieux B. Screening for neuroblastoma in North America: 2-year results from the Quebec project. Am J Pediatr Hematol Oncol 1992;14:312-9.

140. Wujcik D, Ballard B, Camp-Sorrell D. Selected complications of allogeneic bone marrow transplantation. Semin Oncol Nurs 1994;10:28-41.

141. Zeltzer LK. Cancer in adolescents and young adults psychosocial aspects: long-term survivors. Cancer 1993;71(Suppl):3463-8.

142. Zipursky A, Zipursky FS. Caring for children with cancer. Toronto: The Hospital for Sick Children, 1993;2 et 34.

[Précédente] [Table des matières] [Prochaine]